Benitec Biopharma (BNTC) Profit After Tax (2019 - 2025)
Historic Profit After Tax for Benitec Biopharma (BNTC) over the last 7 years, with Q2 2025 value amounting to -$8.8 million.
- Benitec Biopharma's Profit After Tax fell 8462.99% to -$8.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$38.0 million, marking a year-over-year decrease of 7375.26%. This contributed to the annual value of -$37.9 million for FY2025, which is 7393.12% down from last year.
- Per Benitec Biopharma's latest filing, its Profit After Tax stood at -$8.8 million for Q2 2025, which was down 8462.99% from -$14.5 million recorded in Q1 2025.
- Benitec Biopharma's 5-year Profit After Tax high stood at -$3.3 million for Q1 2022, and its period low was -$14.5 million during Q1 2025.
- Over the past 5 years, Benitec Biopharma's median Profit After Tax value was -$5.1 million (recorded in 2021), while the average stood at -$5.9 million.
- Its Profit After Tax has fluctuated over the past 5 years, first skyrocketed by 1621.9% in 2022, then tumbled by 23888.76% in 2025.
- Over the past 5 years, Benitec Biopharma's Profit After Tax (Quarter) stood at -$4.8 million in 2021, then decreased by 12.24% to -$5.4 million in 2022, then dropped by 25.63% to -$6.8 million in 2023, then plummeted by 40.51% to -$9.6 million in 2024, then increased by 7.82% to -$8.8 million in 2025.
- Its Profit After Tax was -$8.8 million in Q2 2025, compared to -$14.5 million in Q1 2025 and -$9.6 million in Q4 2024.